The Effect of Intravenous Small-Volume Sodium Potassium Magnesium Calcium and Glucose Injection on Dizziness in Outpatients Undergoing Painless Gastroenteroscopy: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300071243

Enrollment

Unknown

Registered

2023-05-09

Start date

2023-05-15

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dizziness

Interventions

experimental group:the experimental group was administered of 20ml sodium potassium magnesium calcium and glucose injection before anesthesia

control group:the control group was administered of 20ml 0.9% normal saline before anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. ASA I-II level; 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Known history of neurological disorders, such as dizziness, stroke, epilepsy, and dementia; 2. Severe liver and kidney diseases; 3. Clear electrolyte disturbance; 4. Diabetes mellitus; 5. Body mass index >=30 kg/m^2 or predicted difficult airway; 6. Participated in other studies within the past three months.

Design outcomes

Primary

Measure	Time frame
The incidence of moderate to severe dizziness;	—

Secondary

Measure	Time frame
Dizziness score;Awakening time;The length of the PACU stay;Incidence of nausea and vomiting;Patient satisfaction score(0-10) before leaving PACU;Haemodynamics;	—

Countries

China

Contacts

Public ContactMao Wenjie

Jianyang People's Hospital

maowenjie20210330@163.com+86 152 8221 9022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026